Inventor · disambiguated record
Takeru Ehara
Also filed as: EHARA TAKERU
16 granted patents·11 pending applications·176 citations·filing 2004–2025
91Inventor score
Files withNOVARTIS AG8ADAMS CHRISTOPHER MICHAEL4PEPTIDREAM INC4ADAMS CHRISTOPHER M3BREITENSTEIN WERNER2
Top patents by PatentIndex Score
27 records- 0196US9056874B2Complement pathway modulators and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2013·Granted Jun 16, 2015·95 cites·29 claims
- 0290US8129411B2Organic compoundsEHARA TAKERU·Filed 2006·Granted Mar 6, 2012·40 cites·20 claims
- 0389US9682968B2Piperidinyl-indole derivatives complement factor B inhibitors and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Jun 20, 2017·15 cites·17 claims
- 0485US10093663B2Piperidinyl-indole derivatives complement factor B inhibitors and uses thereofNOVARTIS AG·Filed 2017·Granted Oct 9, 2018·5 cites·18 claims
- 0581US9676728B22-benzyl-benzimidazole complement factor B inhibitors and uses thereofADAMS CHRISTOPHER·Filed 2014·Granted Jun 13, 2017·6 cites·12 claims
- 0680US9475806B2Complement factor B inhibitors and uses there ofADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Oct 25, 2016·6 cites·14 claims
- 0777US8178559B2Organic compoundsBREITENSTEIN WERNER·Filed 2011·Granted May 15, 2012·5 cites·9 claims
- 0875US8084450B2Organic compoundsBREITENSTEIN WERNER·Filed 2005·Granted Dec 27, 2011·3 cites·11 claims
- 0966US7704996B2Compounds and compositions useful as cathepsin S inhibitorsNOVARTIS AG·Filed 2005·Granted Apr 27, 2010·1 cites·7 claims
- 1056US8383650B2Organic compoundsNOVARTIS AG·Filed 2008·Granted Feb 26, 2013·0 cites·6 claims
- 1156US2025326865A1C-met protein-binding peptide complexPEPTIDREAM INC·Filed 2022·Application pending·0 cites
- 1256US2023257343A1Novel amino acid derivativesPEPTIDREAM INC·Filed 2023·Application pending·0 cites
- 1354US2025090699A1Fap targeting cyclic peptides and conjugates thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1452US10550102B2Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activatorsNOVARTIS AG·Filed 2018·Granted Feb 4, 2020·0 cites·15 claims
- 1549US2023203098A1Human transferrin receptor binding peptideJAPAN CHEM RES·Filed 2021·Application pending·0 cites
- 1647US2024010627A1Novel guanidine derivative and method for producing samePEPTIDREAM INC·Filed 2022·Application pending·0 cites
- 1746US2025332300A1Her2 targeting cyclic peptides and conjugates thereofNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1845US10208018B2Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted Feb 19, 2019·0 cites·18 claims
- 1945US8497286B2Organic compoundsYOKOKAWA FUMIAKI·Filed 2012·Granted Jul 30, 2013·0 cites·12 claims
- 2044US2025263440A1Cd38-binding agents and uses thereofPEPTIDREAM INC·Filed 2020·Application pending·0 cites
- 2142US2009137566A1Substituted Piperdines as Renin InhibitorsEHARA TAKERU·Filed 2006·Application pending·0 cites
- 2241US2006247251A12-Cyanopyrrolopyrimidines and pharmaceutical uses thereofBUXTON FRANCIS P·Filed 2004·Application pending·0 cites
- 2340US10316020B2Indane derivatives and the use thereof as soluble guanylate cyclase activatorsNOVARTIS AG·Filed 2016·Granted Jun 11, 2019·0 cites·18 claims
- 2440US2015250767A1Complement pathway modulators and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2015·Application pending·0 cites
- 2540US2010160305A13, 4, 5 - Substituted Piperidine CompoundsNOVARTIS AG·Filed 2006·Application pending·0 cites
- 2632US9765067B2Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted Sep 19, 2017·0 cites·19 claims
- 2731US9957254B2Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted May 1, 2018·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Takeru Ehara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →